课题基金 / 基金详情

TOPIC 345: PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS

TOPIC 345: PREDICTIVE BIOMARKERS OF PROSTATE CANCER PATIENT SENSITIVITY FOR RADIATION LATE EFFECTS
主题 345:前列腺癌患者对辐射迟发效应敏感性的预测生物标志物
批准号:
10029810
负责人:
ANATOLY DRITSCHILO
金额:
$190.31万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-16 至 2021-09-15

项目摘要

项目成果

ANATOLY DRITSCHILO的其他基金

相似基金

相关文献

中文摘要
翻译
为了实现开发“放射治疗不良反应的预测性生物标志物”的目标,我们建议对在I期SBIR工作中开发的产品(“代谢物面板试剂盒”)进行多位点分析验证。在三个独立的、地理分布的检测实验室中,对接受SBRT治疗的前列腺癌患者的血浆代谢物分析结果进行精密度、准确性和可重复性测试。从前列腺癌患者获得的临床样本和添加了已知数量代谢物的样本将被分发,用于Shuttle代谢物“试剂盒”的分析验证。从I期研究中获得的数据已经确定了代谢物组作为辐射晚期效应预测生物标志物的潜在用途。在此,我们提出三个技术目标:
英文摘要
To address the goals of developing "predictive biomarkers of adverse reactions to radiation treatment", we propose to perform a multi-site analytic validation of the product ("metabolite panel kit") developed in the Phase I SBIR effort. Results of plasma metabolite analysis in defined cohorts of patients treated with SBRT for prostate cancer will be tested for precision , accuracy and reproducibility in three independent, geographically distributed testing laboratories. Clinical samples obtained from patients with prostate cancers and samples spiked with known quantities of metabolites will be distributed for analytic validation of Shuttle's metabolite "kit". The data derived in the Phase I effort have defined metabolite panels for potential use as predictive biomarkers of radiation late effects. here, we propose three technical objectives: 1. To manufacture 500 metabolite panel "kits" and analysis software 2. Test and validate the performance of kits and software at three independent sites and 3. With the assistance of regulatory consultant and FDA input, design an expanded multi institutional validation clinical trial to test the metabolite panel kit for use as a potential "metabolite biomarker" for clinical application. Demonstration of proof of principle in patients with prostate cancer may support development and commercialization of the metabolite biomarker product.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Georgetown University AP4 Center Plan
  • 批准号:
    6830482
  • 项目类别:
  • 资助金额:
    $7.76万
  • 财政年份:
    2004
  • 负责人:
    ANATOLY DRITSCHILO
  • 依托单位:
RADIOSENSITIZATION OF PANCREATIC CANCERS THROUGH RAF-1
  • 批准号:
    6651745
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2002
  • 负责人:
    ANATOLY DRITSCHILO
  • 依托单位:
ATM GENE IN BREAST CANCER--PROSPECTIVE CLINICAL TRIAL
  • 批准号:
    6443863
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2001
  • 负责人:
    ANATOLY DRITSCHILO
  • 依托单位:
MOLECULAR STUDIES OF RADIATION RESISTANT TUMOR CELLS
  • 批准号:
    6443857
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2001
  • 负责人:
    ANATOLY DRITSCHILO
  • 依托单位:
海外基金